Study of ro7890597 in healthy volunteers
Treatments studied
This study tests a new medicine called ro7890597 in healthy adults to see how safe it is and how the body handles it. Participation could help determine if this medicine is suitable for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 18 or older.
- Your body mass index (bmi) must be between 18 and 30.
- You must agree to use effective contraception if applicable.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must not have taken certain investigational drugs, immunosuppressive medications, or vaccines within specified timeframes.
- You must not have had major surgery in the last 28 days or plan any during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This trial tests a new oral medication in healthy volunteers to see how it moves through the body and how safe it is. Taking part helps researchers understand how the drug works before it's studied in people with a certain condition.
This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.